4//SEC Filing
DeVinney Erick Wayne 4
Accession 0000805928-25-000028
CIK 0000805928other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:22 PM ET
Size
7.4 KB
Accession
0000805928-25-000028
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
DeVinney Erick Wayne
VP of Clin. & Trans. Sciences
Transactions
- Tax Payment
Common Stock
2025-03-04$18.35/sh−8,296$152,232→ 201,005 total - Exercise/Conversion
Common Stock
2025-02-28+24,799→ 209,301 total
Footnotes (3)
- [F1]This reflects the number of shares issued upon the attainment of certain performance criteria.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance stock units ("PSUs") on February 28, 2025. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
- [F3]The reported price in Column 4 is a weighted average sale price. These shares were sold on March 4, 2025 in multiple transactions at prices ranging from $18.34 to $18.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001595972
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:22 PM ET
- Size
- 7.4 KB